Author : Tronserve | Wednesday, 27 November 2019
SEOUL -- SK C&C, the provider of system integration, consulting and information technology outsourcing services, has partnered with a university hospital to develop and commercialize a big data-based medical artificial intelligence that would be used in scanning of the brain of patients.
SK C&C said Tuesday that it signed a memorandum of understanding with Ajou University Medical Center based in Suwon to develop and commercialize the big data-based artificial medical intelligence (AI) designed to study and analyze pictures of a patient's brain by the second half of 2020.SK C&C and the hospital have co-worked to develop an "AI model for cerebral hemorrhage analytics." As a result, they came with a model that has the expert-level capability to analyze computed tomography (CT) scan images of a human brain and detect cerebral hemorrhage. Cerebral hemorrhage, also known as cerebral bleed, is a type of bleed that occurs within brain tissues or ventricles. The bleeding kills nearby brain cells, causing temporary or permanent brain damage.
SK C&C has developed an algorithm that analyzes shapes by the size of pixels. The hospital has provided CT brain scan images of some 1,400 patients. Ajou University Medical Center Director Yoo Hee-seok said that his hospital and SK C&C would upgrade the big data-based medical AI.
To take the upper hand in the global medical AI market, which is expected to reach $36.1 billion by 2025, global tech companies are upgrading medical AI platforms to release new services. Currently, some 10 South Korean hospitals have adopted Watson, the medical AI software created by Intel.
The Electronics and Telecommunications Research Institute (ETRI), a state-funded research institute, partnered with Dankook University in Seoul last year to jointly research a big data-based AI engine called "CyberDX" that would analyze and study medical records to predict and manage the conditions of patients.
Aju Business Daily